Amgen (AMGN) Work In Process (2013 - 2017)

Amgen has reported Work In Process for 5 years, with the latest figure at $1.6 billion in Q2 2017.

• On a quarterly basis, Work In Process changed N/A year-over-year to $1.6 billion in Q2 2017; TTM through Jun 2017 was $1.6 billion, a N/A change from a year earlier, with the FY2016 full-year figure at $1.6 billion, up 5.17% from the prior year.
• Work In Process was $1.6 billion for Q2 2017 at Amgen, up from $1.5 billion in the prior quarter.
• The five-year high for Work In Process was $2.1 billion in Q4 2013, with the low at $1.3 billion in Q2 2015.
• Average Work In Process over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2014.
• The sharpest annual moves came in 2015 and 2016: Work In Process declined 28.1% in 2015, then advanced 5.17% in 2016.
• Over 5 years, Work In Process stood at $2.1 billion in 2013, then decreased by 24.85% to $1.6 billion in 2014, then slipped by 1.42% to $1.5 billion in 2015, then climbed by 5.17% to $1.6 billion in 2016, then increased by 0.62% to $1.6 billion in 2017.
• The last three Work In Process figures came in at $1.6 billion (Q2 2017), $1.5 billion (Q1 2017), and $1.6 billion (Q4 2016), per Business Quant data.